In addition, the shikonin-treated mice showed a decrease in serum AST, ALT, BUN, and Scr levels compared with those in the control group (Figure 9), which suggested that shikonin could alleviate the liver and kidney dysfunction in tumor xenograft mice. This evidence concerns the gene GPT and neoplasm.